Quote For AMAG Pharmaceuticals, Inc. AMAG.O
AMAG Pharmaceuticals, Inc. (AMAG.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$37.39
30 Nov 2009
-1.08%
$37.80
$37.63
326,276
$37.78
$36.90
$58.23
$22.20
1.66
428,060
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Skaletsky, Mark | Chairman of the Board | -- |
| Pereira, Brian | President, Chief Executive Officer, Director | 1,094,890 |
| Arkowitz, David | Chief Financial Officer, Executive Vice President, Chief Business Officer | 1,118,710 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $647.65 |
| Shares Outstanding (Mil.) | 17.13 |
| Float (Mil.) | 16.98 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 11.41 |
| Current Ratio | 4.38 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 0.00 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 140.43 |
| Price/Book(TTM) | 4.15 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-5.67 |
| Sales(TTM) | $0.27 |
| Book Value(MRQ) | $9.12 |
| Cash Flow(TTM) | $-5.56 |
| Cash(MRQ) | $5.92 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -48.92 |
| Return on Assets(TTM) | -43.18 |
| Return on Investment(TTM) | -48.21 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 91.26 |
| Operating Margin(TTM) % | -2,173.37 |
| Profit Margin(TTM) % | -2,096.73 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
